Table 2.
Outcomes
| Outcome | Total (N = 7,130) | Patients With Serial hsTnT (n = 3,439) | ||||
|---|---|---|---|---|---|---|
| 7 days | 30 days | 90 days | 7 days | 30 days | 90 days | |
| Primary | ||||||
| AMI | 411 (5.8) | 427 (6.0) | 444 (6.2) | 386 (11.2) | 398 (11.6) | 413 (12.0) |
| Secondary | ||||||
| Any MACE | 494 (6.9) | 551 (7.7) | 610 (8.6) | 464 (13.5) | 508 (14.8) | 547 (15.9) |
| Death | 9 (0.13) | 23 (0.32) | 52 (0.73) | 6 (0.17) | 16 (0.47) | 34 (0.99) |
| Revascularization | 267 (3.7) | 328 (4.6) | 360 (5.0) | 256 (7.4) | 307 (8.9) | 330 (9.6) |
Data are reported as n (%).
AMI = acute myocardial infarction; hsTnT = high‐sensitivity cardiac troponin T; MACE = major adverse cardiac events.